Clinical Trials Logo

Stroke clinical trials

View clinical trials related to Stroke.

Filter by:

NCT ID: NCT04737395 Recruiting - Stroke Clinical Trials

Intensive Upper Extremity Training Program During the Early Subacute Phase After Stroke: A Feasibility Study

Start date: November 22, 2020
Phase: N/A
Study type: Interventional

The study assesses the feasibility of a 4-week upper extremity training program emphasizing quality of movement practiced at high intensity and dosage applied during the early subacute phase after stroke.

NCT ID: NCT04733742 Recruiting - Stroke, Acute Clinical Trials

Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke

BRIDGE-TNK
Start date: May 9, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this trial is to investigate whether intravenous rhTNK-tPA prior to endovascular treatment can improve 90-day functional outcome of stroke patients with large vessel occlusion who are thrombolysis-eligible within 4.5 hours of symptom onset.

NCT ID: NCT04726839 Recruiting - Stroke, Ischemic Clinical Trials

Biomarkers algOrithm for strOke diagnoSis and Treatment Resistance Prediction

BOOST
Start date: March 12, 2021
Phase:
Study type: Observational

Triage of acute ischemic stroke (AIS) patients is critical, to decrease time to treatment, and improve functional outcome. The therapeutic standard of care for AIS consecutive to large vessel occlusion (LVO) is the association of intravenous (IV) alteplase administration and mechanical thrombectomy (MT). However, there are limited places where MT can be performed. Therefore, there is a need for innovative tools to identify, in the ambulance, patients with LVO that require MT. Sending the patients at the right, avoiding futile stops (i.e. in places where MT is not available), is definitively a strategy that saves time. There is currently no biomarker nor Point Of Care (POC) Lab Testing to solve this issue and clinical scoring methods such as the NIHSS have a low accuracy rate to detect LVO. The relevance of blood biomarkers for LVO diagnosis and therapeutic decisions needs to be confirmed for effective triage in the setting of AIS with LVO, which represent 30% of all AIS. The main objective of our study is to determine diagnostic performances of a panel of selected blood biomarkers to identify patients with AIS consecutive to LVO among those with stroke suspicion, within 24 hours of stroke symptom's onset before brain imaging. This could facilitate the triage of patients with LVO refractory to thrombolysis treatment, who may benefit most from MT.

NCT ID: NCT04724889 Recruiting - Stroke Clinical Trials

Predictors of Atrial Fibrillation in Patients Undergoing Implantable Loop Recorder Implant

Start date: August 1, 2019
Phase:
Study type: Observational

Implantable Loop Recorders (ILR) are small devices the size of a memory stick, which are implanted to investigate stroke, palpitations and fainting episodes. They monitor the heart constantly and detect abnormalities such as slow or fast heart beats and an irregular heartbeat called Atrial Fibrillation (AF). Stroke is a life threatening condition and no cause is identified for over 30% of strokes. AF is a predominant risk factor for stroke. About 30% of patients with stroke are found to have AF when they are monitored with an ILR. Unfortunately not every patient with a stroke can have an ILR; one of the prohibiting factors is cost. Therefore, there is an urgent unmet clinical need to rationalise the use of ILRs and prioritise their implantation in those patients that have most to gain and therefore achieving cost-effectiveness and improving patient care. In order to achieve the above, identifying parameters that can predict the presence of underlying AF is very important. Studies have shown that special factors including patient's other medical problems, family history, factors on paper recording of the electrical activity of the heart, heart monitors and ultrasound scan of the heart can be useful in predicting AF. Also certain blood molecules have been investigated as potential predictors of AF. The aim of this study is to look at all the above factors and combine them in order to determine whether these factors can predict the presence of AF. Identify predictors of AF will allow doctors to identify patients at different risk of having AF and use the ILR in all possible patients that might need it.

NCT ID: NCT04724824 Recruiting - Stroke Clinical Trials

Validation of a Brain-Computer Interface for Stroke Neurological Upper Limb Rehabilitation

Start date: March 16, 2021
Phase: N/A
Study type: Interventional

The study's main goal is to determine if clinical and physiological effects of a brain-computer interface intervention for the neurorehabilitation of stroke patients' upper limb are greater than the effects of a sham robotic feedback. For this purpose a randomized controlled trial will be performed to compare somatosensory sham robotic feedback with the same somatosensory feedback controlled with the brain-computer interface output.

NCT ID: NCT04721860 Recruiting - Stroke Clinical Trials

Optimizing Training in Severe Post-Stroke Walking Impairment

BLT2b
Start date: October 15, 2020
Phase: N/A
Study type: Interventional

Difficulty walking is common after a stroke. Although physical rehabilitation helps a little with the improvement of walking ability, recovery is usually incomplete. The purpose of this study is to explore how two different treadmill training approaches influence walking speed, symmetry, and balance in people with chronic severe stroke-related walking impairment. The two approaches involve either forward or backwards treadmill training. This study will look at changes in walking performance and balance, before and after training. This study may lead to more efficient methods for improving walking performance and balance after stroke.

NCT ID: NCT04720820 Recruiting - Stroke Clinical Trials

Efficacy and Safety of Early Supported Discharge for Post-Acute Stroke Patients in Korea

KOMPACT
Start date: March 1, 2021
Phase: N/A
Study type: Interventional

The study aims to examine the effect of early supported discharge (ESD) service on the functional outcomes and quality of life of acute stroke patients with mild to moderate disability in Korea. The study is a double-armed prospective multi-centered, assessor-blinded randomized controlled trial comparing the effect of ESD program with conventional rehabilitation program.

NCT ID: NCT04717843 Recruiting - Clinical trials for Embolic Stroke of Undetermined Source

Identification of New Markers of Atrial Myopathy in Patients With Embolic Stroke of Undetermined Source (ESUS) From MRI 4D Data

IRM 4D-AVC
Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Atrial myopathy is considered to be the underlying cause of a large proportion of embolic strokes of undetermined source. However, the definition of this atrial condition is not well delineated while its identification could lead to prescription on anticoagulation in order to avoid stroke recurences. This study aims to identify new markers of atrial myopathy and choosed a multi parametric approach with electrical, echographical, biological and 4D flow CMR derived markers.

NCT ID: NCT04717050 Recruiting - Breast Cancer Clinical Trials

Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity

Start date: August 12, 2021
Phase: N/A
Study type: Interventional

This study is about testing whether exercise will improve fitness and lessen risk factors related to heart disease, diabetes, and obesity in Latina breast cancer survivors.

NCT ID: NCT04716829 Recruiting - Stroke Clinical Trials

LUNA-EMG to Enhance Motor Functions in Neurological Disorders

LUNA
Start date: March 1, 2021
Phase: N/A
Study type: Interventional

The aim of the present study is to evaluate the effects of training performed with the LUNA-EMG system to enhance motor functions of the upper limb in stroke This is a randomized open-label trial. Patients will be randomized into the intervention group (LUNA-EMG) or in the control group (standard care). The effect of the training will be measured with the EMG, the upper limb motor function and the quality of life.